Chappell Dale's Form 4 filing
Humanigen, Inc (HGEN) · filed Oct 20, 2023
- Accession no.
- 0001013594-23-000819
- Filed
- Oct 20, 2023, 6:50 PM ET
- Trade date
- Oct 18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $4.25K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chappell DaleCIK 0001379459 | Director, Officer (Chief Scientific Officer), 10% Owner |
| Black Horse Capital LPCIK 0001178179 | 10% Owner |
| Black Horse Capital Management LLCCIK 0001379554 | 10% Owner |
| Cheval Holdings, Ltd.CIK 0001679225 | 10% Owner |
| Black Horse Capital Master Fund Ltd.CIK 0001679234 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −34,253 | $0.011 | −$376.78 | 1,041,536 | Indirect | |
| Oct 18, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −75,887 | $0.011 | −$834.76 | 2,307,530 | Indirect | |
| Oct 18, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −276,210 | $0.011 | −$3,038.31 | 8,398,871 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.